cabergoline

Generic: cabergoline

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name cabergoline
Generic Name cabergoline
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cabergoline .5 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 59762-1005
Product ID 59762-1005_754ad7cd-edf5-4792-890d-07f0e4324c07
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA020664
Listing Expiration 2026-12-31
Marketing Start 2014-09-22

Pharmacologic Class

Established (EPC)
ergot derivative [epc]
Chemical Structure
ergolines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 597621005
Hyphenated Format 59762-1005

Supplemental Identifiers

RxCUI
199703
UNII
LL60K9J05T
NUI
M0007652 N0000175827

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cabergoline (source: ndc)
Generic Name cabergoline (source: ndc)
Application Number NDA020664 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 8 TABLET in 1 BOTTLE (59762-1005-1)
source: ndc

Packages (1)

Ingredients (1)

cabergoline (.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "754ad7cd-edf5-4792-890d-07f0e4324c07", "openfda": {"nui": ["M0007652", "N0000175827"], "unii": ["LL60K9J05T"], "rxcui": ["199703"], "spl_set_id": ["e497366b-a124-4d7f-bd45-a883c392d4bb"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET in 1 BOTTLE (59762-1005-1)", "package_ndc": "59762-1005-1", "marketing_start_date": "20140922"}], "brand_name": "Cabergoline", "product_id": "59762-1005_754ad7cd-edf5-4792-890d-07f0e4324c07", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "59762-1005", "generic_name": "cabergoline", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cabergoline", "active_ingredients": [{"name": "CABERGOLINE", "strength": ".5 mg/1"}], "application_number": "NDA020664", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20140922", "listing_expiration_date": "20261231"}